# EDGAR Filing Document

**Accession Number:** 0001940499
**File Stem:** 0001193125-25-262137
**Filing Date:** 2025-11
**Character Count:** 8319
**Document Hash:** d2ec38c0565e3aaff3e52a47f6e9a542
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-262137.hdr.sgml**: 20251103

**ACCESSION NUMBER**: 0001193125-25-262137

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20251103

**DATE AS OF CHANGE**: 20251103

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** JPMorgan Private Markets Fund
- **CENTRAL INDEX KEY:** 0001940499

**ORGANIZATION NAME:**
- **EIN:** 000000000

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-94124
- **FILM NUMBER:** 251443059

**BUSINESS ADDRESS:**
- **STREET 1:** 277 PARK AVE.
- **STREET 2:** 21ST FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10172
- **BUSINESS PHONE:** (212) 648-2828

**MAIL ADDRESS:**
- **STREET 1:** 277 PARK AVE.
- **STREET 2:** 21ST FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10172
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** J.P. Morgan Investment Management Inc.
- **CENTRAL INDEX KEY:** 0001363391

**ORGANIZATION NAME:**
- **EIN:** 133200244
- **STATE OF INCORPORATION:** NY
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **STREET 1:** 270 PARK AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
- **BUSINESS PHONE:** 212-270-6000

**MAIL ADDRESS:**
- **STREET 1:** 270 PARK AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** J.P.Morgan Investment Management, Inc.
- **DATE OF NAME CHANGE:** 20060518

### Attached PDF Documents

**Attachment 1:** `ck0000000000-ex99_1.pdf`

_No text found in this document._

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 13)**

**JPMorgan Private Markets Fund**

*(Name of Issuer)*

**Class I common shares of beneficial interest**

*(Title of Class of Securities)*

**48130F306**

*(CUSIP Number)*

**Tyler Jayroe**<br>c/o J.P. Morgan Invest. Mgmt. Inc.<br>277 Park Ave<br>New York NY 10172<br>212-270-6000

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**10/30/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **48130F306** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**J.P. Morgan Investment Management Inc.** | Name of reporting person<br>**J.P. Morgan Investment Management Inc.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**3033788.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**3033788.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**3033788.00** | Aggregate amount beneficially owned by each reporting person<br>**3033788.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**8.1%** | Percent of class represented by amount in Row (11)<br>**8.1%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IA** | Type of Reporting Person (See Instructions)<br>**IA** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Class I common shares of beneficial interest

**(b) Name of Issuer:**
JPMorgan Private Markets Fund

**(c) Address of Issuer's Principal Executive Offices:**
277	Park Avenue, New York, NY, 10172

Explanatory Note

This Amendment No. 13 to Schedule 13D ("Amendment No. 13") is being filed by J.P. Morgan Investment Management Inc. ("JPMIM" or the "Reporting Person") and amends and supplements the statement on Schedule 13D originally filed with the Securities and Exchange Commission on July 24, 2023, as amended by Amendment No. 1 filed with the Securities and Exchange Commission on September 20, 2023, as amended by Amendment No. 2 filed with the Securities and Exchange Commission on December 22, 2023, as amended by Amendment No. 3 filed with the Securities and Exchange Commission on March 21, 2024, as amended by Amendment No. 4 filed with the Securities and Exchange Commission on April 23, 2024, as amended by Amendment No. 5 filed with the Securities and Exchange Commission on July 2, 2024, as amended by Amendment No. 6 filed with the Securities and Exchange Commission on August 30, 2024; as amended by Amendment No. 7 filed with the Securities and Exchange Commission on October 31, 2024; as amended by Amendment No. 8 filed with the Securities and Exchange Commission on December 31, 2024; as amended by Amendment No. 9 filed with the Securities and Exchange Commission on March 4, 2025; as amended by Amendment No. 10 filed with the Securities and Exchange Commission on May 2, 2025; as amended by Amendment No. 11 filed with the Securities and Exchange Commission on July 2, 2025; as amended by Amendment No. 12 filed with the Securities and Exchange Commission on October 2, 2025 (as amended, the "Schedule 13D") related to the Class I common shares of beneficial interest (the "Class I Common Shares") of JPMorgan Private Markets Fund, a Delaware statutory trust (the "Issuer"). The Items below amend the information disclosed under the corresponding Items of the Schedule 13D as described below. Except as specifically provided herein, this Amendment No. 13 does not modify any of the information previously reported in the Schedule 13D. Capitalized terms used herein without definition shall have the meaning set forth in the Schedule 13D.

**Item 4. Purpose of Transaction**

Item 4 of the Schedule 13D is hereby amended and supplemented to include the following:

On October 1, 2025, Reporting Person's agreement to tender Class I Common Shares to the Issuer was accepted. On October 30, 2025, the number of shares being sold by the Reporting Person was fixed when the price per share was determined by the Issuer, following the determination of the Issuer's net asset value as of September 30, 2025. Specifically, the Issuer repurchased 1,152,472.05 shares from JPMIM pursuant to the tender offer for an aggregate sales price of approximately $20,000,000 or $17.3540 per Class I Common Share. The repurchase closed on October 30, 2025.

**Item 5. Interest in Securities of the Issuer**

**(a)**
Item 5(a) of this Schedule 13D is hereby amended and restated as follows:

The information set forth in the cover pages of this Schedule 13D is hereby incorporated by reference into this Item 5.

As of the date hereof, JPMIM may be deemed to beneficially own an aggregate of 3,033,788.021 Class I Common Shares representing approximately 8.13% of the outstanding Class I Common Shares. The percentage of beneficial ownership in this Schedule 13D assumes that there are 37,319,431.595 Class I Common Shares outstanding as of the date hereof based on information received from the Issuer.

**(b)**
—

**(c)**
—

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** J.P. Morgan Investment Management Inc.

**Signature:** /s/ Tyler Jayroe

**Name/Title:** Tyler Jayroe, Managing Director

**Date:** 11/03/2025